4.5 Article

Homologous Recombination Offers Advantages over Transposition-Based Systems to Generate Recombinant Baculovirus for Adeno-Associated Viral Vector Production

期刊

BIOTECHNOLOGY JOURNAL
卷 16, 期 1, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.202000014

关键词

baculovirus expression vector; gene therapy; homologous recombination; manufacturing; rAAV vectors; Tn7 transposition

资金

  1. Fondation d'Entreprise Therapie Genique en Pays de Loire
  2. Region Pays de Loire
  3. Commissariat General a l'Investissement (ANR Program, Investissements d'Avenir, Preindustrial Gene Therapy Vector Consortium) [ANR-10-DBPS-01]
  4. University of Nantes
  5. Centre Hospitalier Universitaire (CHU) of Nantes
  6. INSERM

向作者/读者索取更多资源

Manufacturing viral vectors for gene delivery is challenging, with a scalable baculovirus-insect cell platform being used for producing rAAV vectors. A faster and safer method based on homologous recombination (HR) has been investigated to avoid technical constraints and safety concerns associated with the Tn7 transposition method. The HR system offers increased stability and avoids undesirable bacterial genes, ensuring the generation of safer rAAV biotherapeutic products.
Viral vectors have a great potential for gene delivery, but manufacturing is a big challenge for the industry. The baculovirus-insect cell is one of the most scalable platforms to produce recombinant adeno-associated virus (rAAV) vectors. The standard procedure to generate recombinant baculovirus is based on Tn7 transposition which is time-consuming and suffers technical constraints. Moreover, baculoviral sequences adjacent to the AAV ITRs are preferentially encapsidated into the rAAV vector particles. This observation raises concerns about safety due to the presence of bacterial and antibiotic resistance coding sequences with a Tn7-mediated system for the construction of baculoviruses reagents. Here, a faster and safer method based on homologous recombination (HR) is investigated. First, the functionality of the inserted cassette and the absence of undesirable genes into HR-derived baculoviral genomes are confirmed. Strikingly, it is found that the exogenous cassette showed increased stability over passages when using the HR system. Finally, both materials generated high rAAV vector genome titers, with the advantage of the HR system being exempted from undesirable bacterial genes which provides an additional level of safety for its manufacturing. Overall, this study highlights the importance of the upstream process and starting biologic materials to generate safer rAAV biotherapeutic products.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Selective retinal ganglion cell loss and optic neuropathy in a humanized mouse model of familial dysautonomia

Anil Chekuri, Emily M. Logan, Aram J. Krauson, Monica Salani, Sophie Ackerman, Emily G. Kirchner, Jessica M. Bolduc, Xia Wang, Paula Dietrich, Ioannis Dragatsis, Luk H. Vandenberghe, Susan A. Slaugenhaupt, Elisabetta Morini

Summary: Familial dysautonomia (FD) is a neurodegenerative disease caused by a gene mutation, and visual decline leading to blindness is a significant issue. Researchers have generated a mouse model that accurately replicates the splicing defect observed in FD patients and successfully corrected the retinal defect in the mouse model using a splicing modulator compound.

HUMAN MOLECULAR GENETICS (2022)

Review Biochemistry & Molecular Biology

AAV capsid design: A Goldilocks challenge

S. Zolotukhin, L. H. Vandenberghe

Summary: In vivo therapeutic gene transfer is a novel class of medicines that relies on the safe and effective delivery of genetic material. The adeno-associated virus (AAV) vector has emerged as a preferred gene delivery vehicle, allowing for therapeutic gene expression in various clinical indications. Recent trends in AAV capsid engineering focus on enhancing targeting specificity, safety, and endurance, a significant challenge that is being addressed through techniques such as directed evolution, sequence analysis, and machine learning.

TRENDS IN MOLECULAR MEDICINE (2022)

Article Biochemistry & Molecular Biology

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

Attya Omer-Javed, Gabriele Pedrazzani, Luisa Albano, Sherash Ghaus, Claire Latroche, Maura Manzi, Samuele Ferrari, Martina Fiumara, Aurelien Jacob, Valentina Vavassori, Alessandro Nonis, Daniele Canarutto, Luigi Naldini

Summary: Hematopoietic stem/progenitor cell gene therapy has been successful in treating genetic diseases. Mobilizers provide an opportunity for exogenous cells to efficiently replace depleted bone marrow through competition. This competitive advantage is achieved by rescuing the detrimental effects of mobilization on hematopoietic stem/progenitor cells during ex vivo culture, and can be further enhanced by transient overexpression of engraftment effectors.
Article Medicine, Research & Experimental

Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes

Sophia Grotz, Jessica Schaefer, Kirsten A. Wunderlich, Zdenka Ellederova, Hannah Auch, Andrea Baehr, Petra Runa-Vochozkova, Janet Fadl, Vanessa Arnold, Taras Ardan, Miroslav Veith, Gianluca Santamaria, Georg Dhom, Wolfgang Hitzl, Barbara Kessler, Christian Eckardt, Joshua Klein, Anna Brymova, Joshua Linnert, Mayuko Kurome, Valeri Zakharchenko, Andrea Fischer, Andreas Blutke, Anna Doering, Stepanka Suchankova, Jiri Popelar, Eduardo Rodriguez-Bocanegra, Julia Dlugaiczyk, Hans Straka, Helen May-Simera, Weiwei Wang, Karl-Ludwig Laugwitz, Luk H. Vandenberghe, Eckhard Wolf, Kerstin Nagel-Wolfrum, Tobias Peters, Jan Motlik, M. Dominik Fischer, Uwe Wolfrum, Nikolai Klymiuk

Summary: This study generated the first translational animal model for Usher syndrome type 1, which exhibits characteristics of hearing loss, vestibular dysfunction, and visual impairment similar to human patients. The research also confirmed the therapeutic potential of gene repair and gene therapy for Usher syndrome through in vitro assessments using primary cells from Usher syndrome pigs or patients.

EMBO MOLECULAR MEDICINE (2022)

Article Biotechnology & Applied Microbiology

Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity

Ngoc Tam Tran, Emilie Lecomte, Sylvie Saleun, Suk Namkung, Cecile Robin, Kristina Weber, Eric Devine, Veronique Blouin, Oumeya Adjali, Eduard Ayuso, Guangping Gao, Magalie Penaud-Budloo, Phillip W. L. Tai

Summary: Over the past two decades, significant progress has been made in the manufacturing of adeno-associated virus (AAV) vectors to meet the production demands for preclinical and clinical trials. However, the presence of empty AAV capsids and particles containing inaccurate vector genomes remains a concern. Different methods have been utilized to separate empty capsids from full particles, but no single technique can completely eliminate empty or partial capsids. This study reveals that vectors produced by different manufacturing systems exhibit varying degrees of truncated and unresolved species, and purified empty particles actually contain genomes composed of a single truncated and/or unresolved inverted terminal repeat (ITR). These findings provide valuable insights into the efficacy, safety, and quantification of clinical vectors.

HUMAN GENE THERAPY (2022)

Article Multidisciplinary Sciences

Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates

Michela Milani, Cesare Canepari, Tongyao Liu, Mauro Biffi, Fabio Russo, Tiziana Plati, Rosalia Curto, Susannah Patarroyo-White, Douglas Drager, Ilaria Visigalli, Chiara Brombin, Paola Albertini, Antonia Follenzi, Eduard Ayuso, Christian Mueller, Andrea Annoni, Luigi Naldini, Alessio Cantore

Summary: Liver gene therapy using lentiviral vectors that integrate into the host cell genome has shown efficient liver gene transfer in mice, dogs, and non-human primates. In this study, we compared engineered coagulation factor VIII transgenes and found that codon-usage optimization and inclusion of an unstructured XTEN peptide significantly increased factor VIII expression in mice and non-human primates. Stable and long-term normal or above-normal factor VIII activity was achieved in hemophilia A mouse models. This research opens up new possibilities for treating hemophilia A using lentiviral gene therapy.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates

Thibaut Naninck, Nidhal Kahlaoui, Julien Lemaitre, Pauline Maisonnasse, Antoine De Mori, Quentin Pascal, Vanessa Contreras, Romain Marlin, Francis Relouzat, Benoit Delache, Cecile Herate, Yoann Aldon, Marit van Gils, Nerea Zabaleta, Raphael Ho Tsong Fang, Nathalie Bosquet, Rogier W. Sanders, Luk H. Vandenberghe, Catherine Chapon, Roger Le Grand

Summary: Non-human primates (NHPs) are important preclinical models for SARS-CoV-2 infection. This study found that computed X-ray tomography (CT) and [F-18]-FDG positron emission tomography (PET) have significant benefits in monitoring early infection in NHPs, allowing for early detection of inflammation and lung burden.

ISCIENCE (2022)

Article Cell & Tissue Engineering

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells

Samuele Ferrari, Aurelien Jacob, Daniela Cesana, Marianne Laugel, Stefano Beretta, Angelica Varesi, Giulia Unali, Anastasia Conti, Daniele Canarutto, Luisa Albano, Andrea Calabria, Valentina Vavassori, Carlo Cipriani, Maria Carmina Castiello, Simona Esposito, Chiara Brombin, Federica Cugnata, Oumeya Adjali, Eduard Ayuso, Ivan Merelli, Anna Villa, Raffaella Di Micco, Anna Kajaste-Rudnitski, Eugenio Montini, Magalie Penaud-Budloo, Luigi Naldini

Summary: This study reveals the unexpected load and persistence of AAV genomes and their fragments in gene editing using viral transduction. The accumulation of viral DNA triggers a sustained DNA damage response, leading to frequent integration in cells. Using an integrase-defective lentiviral vector can mitigate the adverse effects and improve gene editing efficiency.

CELL STEM CELL (2022)

Article Medicine, Research & Experimental

Gene therapy with a synthetic adeno-associated viral vector improves audiovestibular phenotypes in Pjvk- mutant mice

Ying-Chang Lu, Yi-Hsiu Tsai, Yen-Huei Chan, Chin-Ju Hu, Chun-Ying Huang, Ru Xiao, Chuan-Jen Hsu, Luk H. Vandenberghe, Chen-Chi Wu, Yen-Fu Cheng

Summary: Recessive PJVK mutations cause a deficiency of pejvakin, leading to hereditary hearing impairment. This study used the synthetic Anc80L65 vector to deliver the PJVKtransgene to the inner ear of Pjvk mutant mice, resulting in the restoration of neuron and hair cell density, and partial recovery of sensorineural hearing impairment.

JCI INSIGHT (2022)

Article Biophysics

Analytical ultracentrifugation sedimentation velocity for the characterization of recombinant adeno-associated virus vectors sub-populations

Sylvie Saleun, Caroline Mas, Aline Le Roy, Magalie Penaud-Budloo, Oumeya Adjali, Veronique Blouin, Christine Ebel

Summary: Recombinant adeno-associated virus virus-derived vectors (rAAVs) are widely used in vivo gene therapies due to their safety profile. However, rAAV production often results in a heterogeneous vector population with undesired empty particles. Analytical ultracentrifugation sedimentation velocity (AUC-SV) is a gold standard technique to measure the relative amounts of each vector subpopulation and components. This letter discusses the principle and practice of using AUC for rAAVs characterization, including the use of interference optics to estimate weight percentages of different capsid populations and the genome size incorporated in rAAV particles.

EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2023)

Article Medicine, Research & Experimental

High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography

Michael Florea, Fotini Nicolaou, Simon Pacouret, Eric M. Zinn, Julio Sanmiguel, Eva Andres-Mateos, Carmen Unzu, Amy J. Wagers, Luk H. Vandenberghe

Summary: The adeno-associated viral vector (AAV) is a safe and efficient gene therapy platform, but the production efficiency, cost, and scalability remain bottlenecks. Chromatographic methods have the potential to address these challenges but require optimization for each serotype.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2023)

Article Biochemistry & Molecular Biology

Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T-cells for the treatment of Hyper IgM1

Daniele Canarutto, Claudia Asperti, Valentina Vavassori, Simona Porcellini, Elisabetta Rovelli, Marianna Paulis, Samuele Ferrari, Angelica Varesi, Martina Fiumara, Aurelien Jacob, Lucia Sergi Sergi, Ilaria Visigalli, Francesca Ferrua, Luis Ignacio Gonzalez-Granado, Vassilios Lougaris, Andrea Finocchi, Anna Villa, Marina Radrizzani, Luigi Naldini

Summary: This study focused on CD40LG gene editing and developed a PCR assay for detecting large on-target deletions. The results showed that large deletions and donor template integrations were common during gene editing. Counter-selection and enrichment methods can reduce the occurrence of on-target deletions. Optical genome mapping was also used to detect genome-wide rearrangements, but no other recurring events were found.

EMBO JOURNAL (2023)

Meeting Abstract Biotechnology & Applied Microbiology

The Choice of Template Delivery Mitigates the Genotoxic Risk and Adverse Impact of Editing in Human Hematopoietic Stem Cells

Aurelien Jacob, Samuele Ferrari, Daniela Cesana, Marianne Laugel, Stefano Beretta, Angelica Varesi, Daniele Canarutto, Luisa Albano, Anastasia Conti, Ivan Merelli, Raffaella Di Micco, Eugenio Montini, Magalie Penaud-Budloo, Luigi Naldini

MOLECULAR THERAPY (2022)

暂无数据